Medovate Ltd and JEB Technologies have become part of the same group structure that will integrate their management, unique skill sets and expertise to drive greater collaboration, innovation and growth in the dynamic field of medical device development.
The strategic move involves two award-winning companies, both deeply committed to accelerating the introduction of pioneering medical technologies that enhance patient safety and care, both in the UK and worldwide.
Medovate and JEB Technologies will combine their strengths across the full medical device development pipeline, from concept design, product development and manufacturing, through to successful regulatory approvals and global market launches.
Medovate’s unique approach to developing technologies in collaboration with the NHS will be complemented by JEB’s extensive manufacturing experience – spanning over 50 years – in developing, manufacturing, and commercialising products globally.
Stuart Thomson, Vice President of Business Development, said: “This is a significant step forward for the medical device industry in the UK’s eastern region, leveraging our organisations’ collective strengths and expertise, along with our respective medical technology pipelines, to accelerate the development of innovative UK medical devices and launch them successfully around the world.
“Medovate’s experienced team will work seamlessly with JEB Technologies to drive innovation development which will positively impact healthcare globally.”
JEB Technologies, with over five decades of experience since its establishment in 1972, specialises in designing, developing and manufacturing a diverse range of medical and industrial products.
It offers an end-to-end product development and manufacturing service, contributing their expertise from concept to commercialisation.
JEB collaborates with medical professionals, innovators and consultants to bring innovative medical ideas to life. JEB Technologies portfolio consists of recently launched prostate biopsy device Camprobe, Transicap and exciting further products currently in development.
Medovate Ltd is recognised for its dedication to providing a route to market for clinician-inspired medical device innovations.
Celebrating its fifth anniversary last year Medovate’s portfolio spans anaesthesia, airway and surgical products, including the pioneering SAFIRA system for regional anaesthesia, Glucosave, Lumevac and Humidicare
Sean Licence Vice President of Operations added: “Developing cutting-edge medical devices involves complex engineering challenges, regulatory requirements and market demands.
“By uniting Medovate’s clinician-inspired model with JEB Technologies’ worldwide manufacturing and design proficiency, we will drive innovation and strengthen our offering to both the medical technology industry and healthcare providers.”
AI helps cut nuisance alerts for healthcare teams
Stabilising the NHS – it’s going to take a lot more than AI
Answer Digital enables speedy deployment of AI with strategic partnerships
Transforming NHS procurement: How good data holds the key to integrated care
British tech firm gets green light on fibroids patent
Cancer leaders pen ‘letter to the world’ calling for urgent investment
Generative AI used to create translatable paediatric care videos for LMIC hospitals
NHS Forth Valley goes live with RCPCH GrowthAPI integrated with Morse Mobile EPR
Mid and South Essex ICS building new shared care record with Orion Health
Red light can reduce blood glucose levels, study finds
- Medtech3 weeks ago
Medtech leadership insights with Barry Warden
- Diagnostics5 days ago
Thousands with cancer-causing condition offered life-saving NHS bowel cancer test
- Digital health4 weeks ago
Assistance app helps blind and visually impaired commuters find bus stops
- Medtech2 weeks ago
Temperature-sensitive prosthesis improves amputee dexterity and feelings of human connection